Table 3 Number of six‐month clinical outcomes.
Variable | No restenosis group (n = 167) | Restenosis group (n = 44) | p Value |
---|---|---|---|
Death | 1 (0.6%) | 0 | 1.000 |
Myocardial infarction | 1 (0.6%) | 2 (4.5%) | 0.111 |
Target vessel revascularisation | 9 (5.4%) | 23 (52.3%) | <0.001 |
Target lesion revascularisation | 0 | 10 (22.7%) | <0.001 |
Percutaneous coronary intervention | 0 | 10 (22.7%) | <0.001 |
Coronary bypass | 0 | 0 | NA |
NA, not applicable.